Zidovudine
Zidovudine is a pharmaceutical drug with 285 clinical trials. Currently 3 active trials ongoing. Historical success rate of 97.5%.
Success Metrics
Based on 269 completed trials
Phase Distribution
Phase Distribution
69
Early Stage
78
Mid Stage
62
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
97.1%
269 of 277 finished
2.9%
8 ended early
3
trials recruiting
285
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma
Early Infant HIV Treatment in Botswana
A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 Years
Clinical Trials (285)
Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma
Early Infant HIV Treatment in Botswana
A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 Years
Antiretroviral Regime for Viral Eradication in Newborns
Study of HIV-Infected and Uninfected Pregnant Woman/Child Dyads in Gaborone, Botswana
Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in Thailand
Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth
A Comparison of Zidovudine (AZT) Used Alone or in Combination With Didanosine (ddI) or Dideoxycytidine (ddC) in HIV-Infected Patients
The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken Zidovudine for More Than 12 Weeks
A Study of Pyrimethamine in the Treatment of Infection by a Certain Parasite in HIV-Positive Patients
A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir
A Study of Zidovudine in HIV-Infected Patients With Liver Disease
Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection
Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI Monotherapy
Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S)
A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma
A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months
The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 285